Evifacotrep, a short transient receptor potential channel 5 (TRPC5) antagonist (WO2020061162, compound 100), can be used for the research of neurological diseases[1].
Evifacotrep is a short transient receptor potential channel 5 (TRPC5) antagonist[1].
















